BRADLEY EDWARDS: Open Payments
NPI 1497026397 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$381 in 23 payments from 9 companies in 2025. Trend: 2023 $619 · 2024 $239 · 2025 $381
Food & beverage: $381
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $94 |
| PFIZER INC. | 5 | $84 |
| AstraZeneca Pharmaceuticals LP | 5 | $81 |
| Exact Sciences Corporation | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Gilead Sciences, Inc. | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
Products named: MOUNJARO, PREVNAR 20, TRUMENBA, AIRSUPRA, FARXIGA, Cologuard Collection Kit, The Cologuard Plus Collection Kit, Kerendia.
Industry payments across OK — which companies pay providers there.
